Acceptance and Commitment Therapy for Depression in Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
Living with spinal cord injury (SCI) can have a significant negative impact on an individual's mental health and restrict participation in personally valued activities and roles. Acceptance and commitment therapy (ACT) is an evidence-based approach that can lessen symptoms of mental health disorders (e.g., depressive symptoms) and improve quality of life through mindfulness and acceptance processes and behavior change processes for valued living. Evidence for ACT for individuals living with SCI, however, is limited to a very few studies that involved in-person group-based ACT and did not focus on depressed individuals with SCI. The primary goal of this study is to evaluate the effects of an 8-week videoconferencing ACT program on improving mental health outcomes in depressed individuals living with SCI. The primary hypotheses are that the ACT group will show improvements in depressive symptoms at posttest and 2-month follow-up compared to the wait-list control group. Investigators will invite 120 individuals living with SCI and reporting depressive symptoms and randomly assign them to either the ACT group or the wait-list control group. The ACT group will receive eight weekly individual ACT sessions guided by a coach through videoconferencing with a booster session at 1-month follow-up. The wait-list control group will continue his or her own care as usual during the study period and have the option to receive eight individual ACT sessions after study participation ends. Data will be collected at pretest, posttest, and 2-month follow-up and compared between the ACT group and the control group over time. About 40% of individuals living with SCI report depressive symptoms and other mental health symptoms, and mental health disorders following SCI are associated with negative long-term outcomes. Managing uncomfortable or painful thoughts and emotions arising from functional limitations and accepting changed lives while moving forward for valued living through ACT skill practice will help individuals with SCI alleviate symptoms of mental health conditions, promote engagement in personally valued activities, and improve quality of life.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual care, especially if you are in the wait-list control group.
What data supports the effectiveness of the treatment Acceptance and Commitment Therapy (ACT) for depression in spinal cord injury?
Research shows that Acceptance and Commitment Therapy (ACT) can help reduce depression in people with physical disabilities and improve well-being in those with psychological issues after brain injuries. This suggests ACT might also be helpful for depression in people with spinal cord injuries.12345
Is Acceptance and Commitment Therapy (ACT) safe for humans?
Acceptance and Commitment Therapy (ACT) is generally considered safe for humans, as it focuses on improving psychological flexibility and helping individuals accept their thoughts and feelings without trying to change them. It has been used for various conditions, including depression and anxiety, without significant safety concerns reported.12367
How is Acceptance and Commitment Therapy (ACT) different from other treatments for depression in spinal cord injury?
Acceptance and Commitment Therapy (ACT) is unique because it focuses on helping individuals with spinal cord injury accept their thoughts and feelings rather than trying to change them, and it encourages them to commit to actions that align with their values, which can help reduce depressive symptoms.12389
Research Team
Areum Han, PhD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults over 18 with spinal cord injuries who feel at least mildly depressed, as shown by a PHQ-9 score of 5 or more. Participants need internet access and a device like a computer or smartphone to join the videoconferencing sessions.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive eight weekly individual ACT sessions guided by a coach through videoconferencing
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a booster session at 1-month follow-up
Wait-list Control
Participants in the wait-list control group maintain their usual care and have the option to receive ACT sessions after the study
Treatment Details
Interventions
- Acceptance and Commitment Therapy (ACT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
The Craig H. Neilsen Foundation
Collaborator